Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou
W Ripley
WR
Medimmune Inc., Gaithersburg, Md., USA.
Kester
Kent E
KE
Heppner
D Gray
DG
D000328:Adult; D000818:Animals; D000852:Anopheles / Q000469:parasitology; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D015195:Drug Design; D005240:Feasibility Studies; D005714:Gambia; D006801:Humans; D007114:Immunization; D007303:Insect Vectors / Q000469:parasitology; D017780:Malaria Vaccines / Q000009:adverse effects / Q000276:immunology; D016778:Malaria, Falciparum / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control*; D008297:Male; D023421:Models, Animal; D010865:Pilot Projects; D010963:Plasmodium falciparum / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology; D012377:Rodentia; D019444:Vaccines, DNA / Q000276:immunology; D022223:Vaccines, Subunit / Q000009:adverse effects / Q000276:immunology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; C041595:circumsporozoite protein, Protozoan